<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5010049 Figure_1-B</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Density of PRBS, defined as the total number of PR-peaks associated to each gene category (up-, down-, and non-regulated genes). PR-peaks were assigned to a gene when located from &#8722;5 Kb upstream of the TSS to the TTS (left panel) or to a window of -/+5Kb around the TSS (right panel). Peak density in the genome was calculated by considering random distribution of all PRBS in the whole genome. Data obtained after exposure to hormone for 5 and 30 minutes is shown. The p-values in comparison with the corresponding non-regulated genes are indicated. Left panel: for PRBs 5 min: *** P=1,04E-035 (UP), *** 2,40E-023 (DOWN); Right panel: PRBs 5 min: ** P=4,64E-008 (UP), * P=0.026 (DOWN).</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_1-C</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Heat Maps of the PRBS associated to up- and down-regulated genes. The log2 normalized signal enrichment centered on PRBs (T0 and R5') located from &#8722;5 Kb upstream of the TSS to the TTS of up- and down-regulated genes is shown (upper panel). Lower panel: The Average profile of PRBs at R5' associated to up-, down- and non-regulated genes is depicted.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_1-E</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Kinetics of PR binding to up- and down-regulated genes. ChIP-seq data of PR obtained after 5, 30, 60 and 360 min of hormone exposure is plotted for up, down (window: -10kb +5kb around the gene) as well as for the proximal promoters of the down-regulated genes (window: -1kb +1kb around the TSS). Lower Panel: normalized enrichment at summits (+/-50bp) of PRBS R5' using the same set as shown in upper panel.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_2-B</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) T47D-MTVLcells were untreated (0) or treated for 6 hours with 10 nM R5020, then the cells were lysed and total RNA was prepared, cDNA was generated and used as template for real time PCR with specific primers for BCAS1, KRT23 and IGFBP5 genes. The values were normalized with GAPDH and represent the mean and standard deviation from 3 experiments performed in duplicate. * P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_2-C</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) T47D-MTVL cells were untreated or treated for 5 and 30 min with hormone and submitted to ChIP assays with anti-PRS294phos antibody or IgG as control. The histograms show the mean &#177; SD of 3 experiments performed in duplicate. * P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_2-D</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) ChIP assays with -MSK1 and -ERK2. Precipitated DNA was analysed by PCR for the presence of sequences corresponding to the BCAS1 and KRT23 genes. * P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_2-E</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) T47D-MTVL cells were untreated (0) or treated for 5 min with 10 nM R5020 and subjected to ChIP assays with a-PR, a-LSD1, a-HP1y and H3K9me3 specific antibodies. The precipitated DNA fragments were subjected to PCR analysis to test for the presence of sequences corresponding to the BCAS1, KRT23 and IGFBP5. The values represent the mean and standard deviation from 3 experiments performed in duplicate. * P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_2-F</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) T47D-MTVL cells transfected with control or HP1y siRNAs, were incubated with 10 nM R5020 for 6h. RNA was extracted, and cDNA was generated and used as a template for real-time PCR with BCAS1, KRT23, IGFBP5, and GAPDH specific primers. The histograms show the mean &#177; SD of 3 experiments performed in duplicate. The levels of HP1y and tubulin were analyzed by western blotting using specific antibodies. * P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_3-A</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) T47D-MTVL cells were treated with R5020 as indicated and subjected to ChIP assays with a-BRG1 or control IgG. Precipitated DNA was analysed by PCR for the presence of sequences corresponding to the BCAS1, KRT23 and IGFBP5. The histograms show the mean &#177; SD of 3 experiments performed in duplicate. * P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_3-B</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) T47D-MTVL or T47DY (PRA-/PRB-) cells were treated or not with hormone and subjected to ChIP assays with antibodies to BRG1. * P-value &lt; 0.05. The levels of PR and BRG1 were analyzed by western blotting using specific antibodies (right panel).</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_3-C</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) T47D-MTVL cells treated or not with hormone were lysed and immunoprecipitated either with a-HP1y specific antibody or mouse IgG. The immunoprecipitates (IP) were analyzed by immunoblotting with PRS294phos, PR, BRG1, BAF170, BAF57, KDM1 and HP1y specific antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_3-D</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D) Protein-fractionation of hormone-treated T47D cell lysates by FPLC with Superose 6 sizing column was analyzed by immunoblot with BRG1 and BAF170 specific antibodies (upper panel). The BAF complex containing BRG1 and BAF170 as well as a smaller complex of BRG1 are indicated (upper panel). Then, IP of BRG1 in the BRG1 eluting fractions from the Superose 6 was performed followed by western blot with BRG1, BAF170, BAF155, LSD1 and HDAC1 (lower panel). The scheme with the protocol is shown (left panel).</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_3-E</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E) T47D-MTVL cells transfected with control or BRG1 siRNAs were treated with 10 nM R5020 as indicated; cDNA was generated and used as template for real time PCR with gene-specific primers. The histograms show the mean &#177; SD of 3 experiments performed in duplicate. * P-value &lt; 0.05. The extent of BRG1 knockdown was monitored by RT-PCR (pink column) and western blot (right panel). BC: BCAS1, KR: KRT23 and IG: IGFBP5 genes.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_3-F</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>F) Cells were transfected with siRNAs and treated with 10 nM R5020 as indicated, and the levels of repressed genes was measured by RT-PCR. The extent of knockdown was analyzed by western blotting using specific antibodies (lower panel). * P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_3-G</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Cells were transfected with control or BRG1 and BRM (B/B) siRNAs and treated with 10 nM R5020 as indicated, and the levels of repressed genes was measured by RT-PCR. * P-value &lt; 0.05. BC: BCAS1, KR: KRT23 and IG: IGFBP5 genes.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_4-B</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) B/B knockdown reduces R5020-induced cell proliferation of T47D-MTVL cells. T47D-MTVL cells were transfected with control or B/B siRNAs and treated with 10 nM R5020 as indicated, and the cell proliferation ELISABrdU Colorimetric assay (Roche) was performed. The percentage of increase in proliferation is shown for each condition. Bars represent mean &#177; SD (n = 5). * P-value &lt; 0.05; ** P-value &lt; 0.01; *** P-value &lt; 0.001</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_4-D-E</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 4-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D-E) Genome-wide distribution of BRG1 around all PRBs or PRBs associated to up, down or non-regulated genes (Panels D and E, respectively). The overlapping between PRBs and BRG1 is also shown (Panel D, inset).</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_4-F</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) The overlapping of BRG1 with BAF170 binding regions is shown for T47D cells (left panel). More regions of BRG1 alone were found associated with hormone-repressed genes compared with BRG1-BAF170 and random regions (right panel). * P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_5-A</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) ChIP assays with -H2A, -H4 and -H1. Precipitated DNA was analysed by PCR for the presence of sequences corresponding to the BCAS1, KRT23 and MMTV genes. * P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_5-B</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Left panel: ChIP-seq experiment using H1.2 specific antibody in untreated and cells exposed to hormone. The ratio between +R5020/T0 around the TSS (-475 +400) of the up, down and non-regulated genes is shown. Right panel: down-regulated genes presented an inverse trend for RNA pol II signal around the TSS (-475 +400) after hormone compared with Up and down-regulated genes. (*) P-value &lt; 0.05; (***) P-value &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_5-C</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) ChIP-seq experiments in T47D-MTVL cells expressing HA-tagged versions of the different H1 isoforms in untreated and cells exposed to hormone. The median corrected ratio between +R5020/T0 around the TSS (-475 +400) of the up, down and non-regulated genes is shown. A significant increase of the signal for H1.2 after hormone exposure was found in down-regulated genes compared with up and non-regulated genes. The median-corrected ratio represents the R5020/T0 ratio corrected by the median values obtained from the TSS of non-regulated genes for each isoform. (***) P-values for H1.2 DOWN vs NON: 2.5x10-68, P-value: DOWN vs UP: 8.3x10-72, UP vs NON: 2.7x10-6.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_5-D</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Hormone-dependent deposition of H1.2 was quantified in down-regulated genes, which presented PRBs (PRBs+) or not (PRBs-) in their promoter region. (*) P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_5-E</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) T47D-MTVL/H1.2 and H1.3 knock-down cell lines (Sancho et al., 2008) treated or not for 6 days with DOX to induce specific H1 depletion, were incubated for 6h with 10nM R5020 as indicated; cDNA was generated and used as template for real time PCR with gene-specific primers. The extent of knockdown was analyzed by western blotting using specific antibodies (lower panel). (*) P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_6-A</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) T47D-MTVL cells treated or not with hormone were lysed and immunoprecipitated either with &#945;-BRG1 specific antibody (upper panel) or H1.2 (lower panel). The immunoprecipitates (IP) were analyzed by immunoblotting with BRG1, H1.2, H1.3, H1.5 and BAF170 specific antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_6-B</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) T47D-MTVL cells transfected with control or BRM and BRG1 (B/B) siRNAs were induced or not with hormone, and subjected to ChIP assays with a-H1. Precipitated DNA was analysed by PCR for the presence of sequences corresponding to the BCAS1, KRT23, IGFBP5, VAMP1, CCDC173 and RAB3D genes. The histograms show the mean &#177; SD of 3 experiments performed in duplicate. * P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_6-C</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) T47DML cells treated or not with hormone were subjected to micrococcal nuclease (MNase) digestion of chromatin followed by high-throughput paired-end DNA sequencing (MNase-seq). Snapshot of the genome browser for the BCAS1 gene is depicted. The expected MNase protection pattern around the TSS and gene body is observed and coincides with regions enriched in H2A.Z, H3K27ac and H3K4me3.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_6-D</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) T47D-MTVL cells treated or not with hormone were subjected to MNase-seq. To quantify the translational positioning of nucleosomes we calculated positioning mean scores for up and down-regulated genes in a region between -800 +400 from the TSS of all protein coding genes (Gaffney et al., 2012). Genes with nucleosome scores were divided into four quantiles (Q) according to the effect of the hormone. (***) P-value &lt; 0.001. Lower panel: Percentage of genes found in quantiles Q1-Q4. In Q1, which presented increased positioning scores after hormone we found significantly more repressed than activated genes, while no significant differences where found in the Q4 with decreased positioning scores. * P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_6-E</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) T47D-MTVL cells transfected with control siRNA or siRNA against BRM and BRG1 (B/B) were induced or not with hormone, subjected to MNase-seq and the positioning scores were calculated as previously reported (Gaffney et al., 2012). The increase in positioning after hormone in repressed genes found in Q1 was not observed when the ATPases are missing. (***) P-value &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_6-F</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) T47D-MTVL cells transfected with control or B/B siRNAs were treated or not with hormone and subjected to DNAse I accessibility assays (see Materials and Methods section). Each value corresponds to the mean &#177; SD of 3 experiments performed in duplicate. (**) P-value &lt; 0.01.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_6-G</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 6-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) The reads obtained by DNAse-seq (Song and Crawford, 2010) in T47D-MTVL cells around PRBs in the absence and in the presence of hormone were quantified and expressed as signal/bp (to account for peak length variation) for up and down-regulated genes. Up-genes: CORO2B, KCNH1, KLF15 and ATP10A; down-genes: KRT23, BCAS1, IGFBP5 and PGR. (*) P-value &lt;0.05, ** P-value &lt;0.01.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_7-A</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) T47D-MTVL cells treated or not with hormone were subjected to ChIP-seq assay with a-FOXA1 (see materials and methods). The number of genes with FOXA1 peaks found in different windows around the TSS is shown. Proximal promoter window: -/+ 1Kb around TSS. (*) P-value &lt;0.05, ** P-value &lt;0.01 and *** P-value &lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_7-B</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) FOXA1 is significantly enriched at PRBs localized in repressed genes compared with up- and non-regulated genes. Lower Panel: heat maps of the results shown in the upper panel. (***) P-value &lt; 10-7.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_7-C</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Cells were transfected with control or FOXA1 siRNAs and treated with 10 nM R5020 as indicated, and the levels of repressed genes were measured by RT-PCR. * P-value &lt;0.05. BC: BCAS1, KR: KRT23 and IG: IGFBP5 genes. The extent of knockdown was analyzed by western blotting using specific antibodies (right panel).</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_7-D</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) T47D-MTVL cells transfected with control or FOXA1 siRNAs were induced or not with hormone, and subjected to ChIP assays with a-BRG1 and IgG as control. Precipitated DNA was analyzed by PCR for the presence of sequences corresponding to the BCAS1, KRT23 and IGFBP5 genes. The histograms show the mean &#177; SD of 3 experiments performed in duplicate. * P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5010049 Figure_7-E</id>
    <infon key="sourcedata_document">2080</infon>
    <infon key="doi">10.15252/embj.201593260</infon>
    <infon key="pmc_id">5010049</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) T47D-MTVL cells treated or not with hormone were lysed and immunoprecipitated either with a-FOXA1 specific antibody (upper panel) or BRG1 (lower panel). The immunoprecipitates (IP) were analyzed by immunoblotting with BRG1, PR and FOXA1 specific antibodies. The inespecific band in the control IgG of the FOXA1IP, which does not coincide with PRB or PRA is also shown in a shorter exposition (right panel).</text>
    </passage>
  </document>
</collection>
